AU627712B2 - Oligonucleotide probes for detection of periodontal pathogens - Google Patents

Description

VNWO 89/06704 PCT/US89/00072 1 OLIGONUCLEOTIDE PROBES FOR DETECTION OF PERIODONTAL PATHOGENS BACKGROUND OF THE INVENTION Technical Field of the Invention This invention relates to compositions of oligonucleotide probes for use in the detection of bacteria associated with medical disorders of the human mouth, wherein said probes consist essentially of a segment of nucleic acid capable of selectively hybridizing under hybridizing conditions, to the 16S or 23S ribosomal RNA [rRNA] of said bacteria. Methods for detection, as well as diagnostic kits for the assay of these bacteria, are also disclosed.

Substantial evidence exists implicating plaque bacteria in the etiology of human periodontal disease, particularly gingivitis and periodontitis. As these diseases have been studied, increasingly sophisticated methods for detection, quantitation, and identification of specific oral bacteria and other infectious viruses and microorganisms have been developed. These improved methods have led to the identification of specific pathogenic bacteria playing a major role in the etiology of periodontal disease.

Human periodontal diseases constitute a major health-care problem in the United States. While epidemiologic surveys suggest that there may be a reduction of the proportion of Americans with gingivitis in recent years, the number of patients having some stage of the disease remains high. Furthermore, the proportion of adults, aged 18-79 years, with periodontal pockets appears to be relatively unchanged.

In the early 1970's, roughly 30 percent of Americans had significant periodontal disease problems by age 50, and by age 60, between 30 and 40 percent of all Americans had lost all of their teeth, primarily due to WO 89/06704 PCT/US89/0072 2 periodontal disease. At present, the exact proportion of persons with severe periodontal disease is unknown, but recent estimates are that 10-20 percent of the ovrall American population has periodontal disease seri&us enough to result in tooth loss. Coincidental with the disease is a significant relationship between the onset and courset of the disease, and identifiable (suspect) pathogenic bacterial species.

Although the precise complex mechanisms involved in the pathogenesis of human periodontitis' are still unclear, there is wide agreement that bacteria that colonize the gingival crevice area around the teeth are of primary etiologic importance. Within the past decade, researchers at several academic institutions have demonstrated that of the large number of bacterial genera and species found in the human periodontal crevice or pocket (ca. 256 species), a relatively limited number of these appear to be consistently associated with periodontal disease. These microorganisms have been designated "suspect periodontal pathogens'.'" Of particular interest are the microorganisms shown in Table 1.

INFORMATION DISCLOSURE The detection and characterization of the periodontal pathogenic bacteria present in a given periodontal pocket site are, by current methods, both time-consuming and expensive microscopic, cultural, gas chromatographic and metabolic product analysis). Furthermore, highly trained individuals, with sophisticated laboratory equipment, are required. Most 30 of the published studies on the microbiology of human periodontal diseases have been compromised by the enormous workload that must be accomplished to isolate and characterize ,ndividual members of the microflora at each periodontal site. As a result, the number of sites sampled per patient and the number of patients examined are limited. Clearly, the present methods do not allow

I

WO 89/06704 PCT/US89/00072

S

3 routine testing of periodontal patients for the presence of pathogenic bacteria.

Immunoassays are reported as an alternative to the above detection methodologies. Fluorescent monoclonal antibodies to Actinobacillus actinomycetemcomitans Bacteroides gingivalis and Bacteroides intermedius have been developed. Chen, et al., The Use Of Monoclonal Antibodies To Detect Bacteroides gingivalis In Biological Samples, Infection and Immunity, 54:798-803 (1986); Gmur, et al., Quantitative Monitoring Of The Periodontal Pocket Flora With Monoclonal Antibodies, Journal of Dental Research Vol.

66:120 (1987, abstract); Fine, D.H. and Mandel, I.D.

Indicators Of Periodontal Disease Activity: An Evaluation, J. Clin. Periodontal, 13:533-546 (1986). These antibodies can be used directly on plaque smears on microscope slides. The testing requires manual counting of fluorescent bacteria on individual microscope slides, a procedure which is very labor-intensive and requires an expensive fluorescent microscope.

The potential for using nucleic acid, hybridization technology to detect pathogenic bacteria is known and, more specifically, the use of rRNA for hybridization assays is known (Canadian Patent No. 1,215,904 and Oligonucleotide Probes Complementary to Variable Regions of Ribosomal RNA Discriminate between Mycoplasma Species.

J. General Microbiology (1987) 133, 1969-1974. U.B.

Gobel, A. Geiser, E.J. Stanbridge/ Whole genomic DNA probes have reportedly been used to identify periodontal pathogens (EP 199,439), but these methods do not possess the hybridization specificity of the disclosed invention.

For example, fragments of or B.i. genomic DNA have been cloned into the pSP64 transcription vector, Chen, et al., Development Of DNA Probes For Oral Microorganisms, Assoc. Adv. Dental Res. Meetings, Wash., D.C. (1986); Savitt, et al., Detection of A.

actinomycetencomitans In Plaque By RNA Probes, Assoc.

i 4 WO 89/06704 PCT/US89/00072 Adv. Dental Res. Meetings, Wash., D.C. (1986). The pSP64 vector is used to produce A.a, or B.i. RNA transcripts. A pSP64-A.a. probe was reporced to be specific when tested against pure cultures or plaque samples. However, pSP64-B.g. and pSP64-B.i. probes cross-hybridized slightly with some non-B.g. and non-B.i.

bacteria, respectively. Since non-pathogenic Bacteroides species are abundant in the subgingival crevice, these cross-hybridizations may cause false positive identifications.

Each of the above methods of detecting periodontal pathogens lacks one or more of the following criteria necessary for a routine diagnostic assay: 1) cost (inexpensive); 2) batch capability; 3) speed (hours, not days or weeks); 4) sensitivity; 5) specificity; 6) multiple pathogen identification in one test; 7) simplicity; and 8) ability to detect both viable and nonviable organisms. Consequently, there is a need in the art for alternate detection methodologies.

SUMMARY OF THE INVENTION The present invention is directed to compositions of oligonucleotide probes for the detection of bacteria associated with human oral medical disorders, wherein said probes comprise a segment of nucleic acid capable of selectively hybridizing, under hybridizing conditions, to hypervariable regions of ribosomal RNA of the bacteria with the provision that any additional nucleotides covalently bound to said segment do not hybridize under said conditions to nucleic acids of bacteria commonly found in the human mouth. Functionally, these probes are able to hybridize to unique portions of the bacterial rRNA or corresponding genoniic DNA permitting ready detection and identification of such bacteria without cross-reacting with other bacterial species. In addition, compositions of oligonuleotide probes directed to conserved regions of 16S and 23S ribosomal RNA are 1 L- SWO 89/06704 PCT/US89/00072 described, wherein said probes can be utilized as specific probes for ribosomal RNA or the corresponding genomic sequence, and can be used for sequencing of ribosomal nucleic acids.

This invention is also directed to a probe of the formula: [X Y Z] wherein: a) X is a sequence of 0 to 100 nucleotides or nucleotide analogs that are non-homologous to conserved or non-conserved regions of.bacterial nucleic acid found in bacteria inhabiting human mouths; b) Y is a sequence of 10 to 100 nucleotide or nucleotide analogs that are capable of hybridizing under hybridizing conditions to hypervariable regions of the ribosomal RNA of bacteria inhabiting human mouths, such that Y may also comprise subsequences that are capable of hybridizing under hybridizing conditions to only one species of said bacteria, to two species of said bacteria or to three species of said bacteria; c) Z is a sequence of nucleotides the same as or different from X, such that nucleotides or nucleotide analogs are non-homologous to conserved or non-conserved regions of nucleic acid of bacteria found inhabiting human mouths; and d) n is 1-500, or more and, where n is greater than 1, Y can be the same or different sequences of nucleotides having said hybridization capability. The probe can be free or contained within a vector sequence plasmids or Single Stranded DNA).

The foll wing bacteria are of particular interest, because they have been found in association with periodontal disease: Actinobacillus (ex.

Haemophilus) actinomycetemcomitans; Bacteroides gingivalis; Bacteroides intermedius Type 1; Bacteroides intermedius Type 2; Eikenella corrodens; Bacteroides forsythus; Fusobacterium nucleatum; Fusobacterium perio-

IX

I~ i WO 89/06704 PCT/US89/00072 6 donticum; Streptococcus intermedius; Wolinella recta.

This invention discloses compositions comprising polynucleotide probes able to hybridize to rRNA of these bacteria, especially the hypervariable regions of the 16S and 23S rRNA.

It is preferred that each specific probe hybridize to the rRNA of only one microbial species or type. Especially preferred are sequences complementary to the hypervariable regions of the 16S rRNA, as offered in Table 1, but these are not intended to be'limiting.

Alternative sequences are readily ascertainable using the sequencing methods disclosed herein. For example, sequences for the hypervariable regions from the 23S ribosomal RNA could be determined using the sequencing primers shown in Table 2. Using the methods disclosed herein, one of skill in the art could readily obtain alternative rRNA sequences with suitable specificity for use in this invention.

The nucleic acid sequence of the claimed probes include synthetically derived or recombinant nucleic acid sequences which have sufficient identity with the claimed sequences that they substantially hybridize with regions complimentary to the claimed probes. By "substantially", it is meant that under standard hybridization conditions of modea;te stringency, percent hybridization can be shown to exceed 50% of the hybridization between perfectly complimentary nucleic acid fragments.

By "compositions", it is meant that probes complementary to bacterial rRNA may be in a pure state or in combination with other probes. In addition, the probes may be in combination with salts or buffers, and may be in a dried state, in an alcohol solution as a precipitate, or in an aqueous solution.

The phrase "and combinations thereof,"' in the context of bacterial groups, refers to compositions of probes designed to detect one or more of the bacterial species stated. The probes may be a mixture of different 4 4

I

11 L TWO 89106704 PCT/US89/00072 7 probes capable of detecting a single species or two or more species, a mixture of different probes wherein the probes are each able to detect one or more species, or a homogeneous composition of a single probe. In the context of oligonucleotide sequences, the phrase "and combinations thereof" refers to a composition of copies of a single probe that may contain as a part of the probe one or more copies of a single oligonucleotide sequence or a mixture of the given sequences, or a mixture of probes that may contain as a part of the probes single or multiple copies of the given oligonucleotide sequences.

The terms oligonucleotide or polynucleotide probes are meant to include both double stranded and single stranded DNA or RNA. The terms also refer to synthetically or recombinantly derived sequences essentially free of non-nucleic acid contamination.

In addition to composition claims, methods are disclosed for the detection of a microbial cell associated with a medical disorder, in a sample obtained from the mouth of a human patient. These methods comprise the steps of: lysing the microbial cells to free the ribosomal RNA; contacting said ribosomal RNA, under hybridizing conditions, with polynucleotide probes capable of selectively hybridizing to the hypervariable regions of the ribosomal RNA of said microbial cell; and detecting hybridization complexes as an indication of the presence of the microbial cell in the sample. More specifically, there is disclosed herein the above method, where the bacteria detected are selected from the above list. Even more specifically, there is disclosed herein a method, as described above, in which the samples are assayed using at least two different groups of probes where each group is capable of hybridizing to a different hypervariable region of the ribosomal RNA of a single bacterium, In addition to the above compositions and methods, there are disclosed herein diagnostic kits rfr WO 89/06704 PCT/US89/00072 I 8 Suse in determining the presence of bacteria which comprise a synthetic oligonucleotide probe complementary to hypervariable regions of the ribosomal RNA of a microbial cell associated with a human oral medical disorder.

The taxonomy of these bacteria is not static.

Type cultures are available from the American Type Cul- Sture Collection (ATCC), Rockville, Maryland. As other bacteria are identified or other subtypes are differentiated from the above list, the disclosed invention readily provides methods for preparing probes of sufficient specificity for use in the detection and identification of these bacteria.

A composition of polynucleotide probes is also Sclaimed wherein said probes comprise a segment of nucleic acid capable of selectively hybridizing to regions of Sribosomal RNA of the bacteria having minimal secondary or tertiary interactions with adjacent nucleotides (open regions), said probes substantially binding only to open regions. By "substantially binding" it is meant that the i 20 probe d not comprise significant sequences that bind to regic.ns that are available for hybridization only after heating, that is, regions with significant secondary and tertiary structure (closed regions). In practical terms, such probes will generally not comprise any more than flanking nucleotides (either 5' or which would bind to closed regions.

More specifically, compositions of polynucleotide probes complementary to open regions are claimed that are complementary to both hypervariable and conserved regions of bacterial rRNA.

A compostion of polynucleotide probes is also claimed that hybridize to closed, conserved regions of bacterial rRNA.

Finally, methods are disclosed for the detection of microbial cells in a sample obtained from the mouth of a human patient. The method comprising the steps of: lysing the microbial cells to free the ribosomal RNA- S WO 89/06704 PCT/US89/00072 9 contacting said ribosomal RNA, under hybridizing conditions, with polynucleotide probes capable of selectively hybridizing to open regions of the ribosomal RNA of said microbial cell; and detecting hybridization complexes as an indication of the presence of the microbial cell in the sample. More specifically, there is disclosed herein the above method, where the bacteria detected are selected from the above list. Even more specifically, there is disclosed herein a method, as described above, in which the samples are assayed using at least two different groups of probes where each group is capable of hybridizing to a different conserved region of the ribosomal RNA of a single bacterium, DETAILED DESCRIPTION This invention relates to the development of species specific nucleic acid probes complementary to the rRNA of species of oral bacteria associated with periodontal disease and other bacterial mediated diseases of the mouth. These probes are superio' to probes complementary to genomic sequences because of their specificity and sensitivity. These probes have been selected for their ability to avoid cross-hybridizing with nonpathogenic bacterial species. Their superior properties are de to the ability to hybvidize exclusively to hypervariable sequences of rRNA, which appear in hundreds to thousands of copies throughout each bacterial cell. The hypervariable regions of rRNA are sequences which are peculiar to a particular bacterial species or type. When compared with probes derived from Whole genomic libraries, probes to rRNA, especially those complementary to hypervariable regions or rRNA, ere advantageously sensitive and specific in their ability to detect low numbers of bacteria and to distinguish between bacterial species, types, and subtypes. It is preferred that the assays comprise capture oligonulceotides to two different hypervariable regions of the same bacterial ribosomal WO 89/06704 PCT/US89/00072 n RNA. Such a format dramatically reduces the incidence of false negative results due to heterogeneity in the selected target regions. The methods disclosed herein have the advantage of being rapid assays. The disclosed methods are relatively simple to conduct, and they have a degree of reproducibility and accura.-t' that has heretofore not been achieved for bacterial pathogens of the mouth.

Sample Collection Microbial specimens for use in this invention can be obtained from the ATCC for any of the bacteria listed in Table 1. For clinical studies, samples are obtained from teeth scrapings of subgingival plaque or from fluid taken from periodontal pockets with paper points of human patients suspected of having periodontal disease. The samples are dispersed in a buffer, which provides a biologically compatible solution, such as 150mM NaCl, Tris-HCl (pH 10mM EDTA, 10mN EGTA, or 150nM S rNaCl, 20mM NaPO 4 (pH 10mM EDTA,''10mM EGTA, and frozen until use. Prior to assay, the cells are optionally cultured in accordance with standard microbiological techniques, such as those described by Dzink, et al., J. Clin. Micro., 19:599, 1984. The bacteria are lysed in a lysis buffer containing N-acetylmuramidase (lysozyme). Lysing buffers are known in the art- EP 199,439; Potts, T.V. and Berry, Em. Internat. J.

Sys. Bacter., 33:765-771 (1983); Bonta, et al., 1 Dent. Res., 64:793-798 (1985). Generally, these buffers are between pH 7.0 and 8.0, containing both chelating agents and surfactants. Heat denaturing is optional.

Alternatively, samples are dispersed and collected directly in a lysing solution that also functions as a hybridization solution, such as 3M guanidinium thiocyanate (GUSCN), 50mM Tris (pH EDTA, 0.1% sodium dodecylsulfate (SDS), and 1% mercaptoethanol (Maniatis, T. et al. Molecular Cloning: iIt I 'WO 89/06704 PCT/US89/00072 A Laboratory Manual, Cold Spring Harbor, New York, 1982).

Lysis is performed at 65°C for 10 min.

Probes Complementary to the rRNA of Orally Pathogenic Bacteria This invention is directed to probes complementary to hypervariable regions of the rRNA sequence that are not conserved between bacterial species or types, and these probes can thus distinguish between species or types. Five sequences within 16S rRNA were derived using three universal oligonucleotide primers described by Lane et al., Proc. Natl. Acad. Sci., U.S.A., 82:6955-6959 (1985), and the following three oligonucleotide primers developed by us: UP4BI 5'GCTGGCACGGAGTTAGCCG3'1 UP8B: 5'CACGARCTGACGACARCCATGC3'; and UP6B: The nomenclature for incompletely specified bases in the nucleic acid sequences are those recommended by the International Union of Biochdmistry, Proc. Natl. Acad.

Sci., U.S.A. 83:4-8 (1986), which is herein incorporated by reference. For example, nucleotides designated R are interchangeable with guanosine, adenosine, or their analogs; nucleotides designated N means any of the natural nucleosides or their analogs may be interchanged at this position. Nucleotides designated Y are interchangeable with cytosine or thymine, nucleotides designated W are interchangeable with adenosine or thymine; nucleotides designated M are interchangeable witn adenosine or cytosine.

i..

Thbse oligonucleotide primers are specific for conserved regions of the prokaryote 16S rRNA, and can be used to prime whole nucleic acid preparations without pretreatment with DNase or physical separations of RNA from DNA. Commercial preparations of reverse transcriptase, along with appropriate primer extension i reactants for sequencing on electrkphoretic gels, are I .2 WO 89/06704 PCT/US89/00072 12 used to obtain transcripts of cDNA complementary to the hypervariable regions of each pathogenic bacteria. The preferred sequencing methodology will use dideoxynucleotide chain termination. Similarly, oligonucleotide primers specific for conserved regions of the prokaryote 23S rRNA (Table 2) have been used to sequence nucleic acid preparations using known sequencing methodology.

The oligonucleotide probes shown in Table 2 are complementary to conserved regions of the prokaryote 16S and 23S ribosomal RNA, and will hybridize under hybridizing conditions to ribosomal RNA and its corresponding genomic DNA sequence. These universal oligonucleotide probes are also ideally suited to be utilized as signal oligonucleotides to DNA and especially RNA of all bacteria. In the multiple dipstick format (see later) the target nucleic acids are captured by probes specific for hypervariable regions while only one universal signal probe derived from the conserved regions of ribosomal RNA can be used to detect the nucleic acid from all the different pathogenic bateria. In addition, it is possible to increase the strength of the signal by 1, ng more than one universal signal oligonucleotide probe.

After sequence analysis of the pathogens is complete for the 16S or 23S rRNA, the sequences can be compared by commercially available computer programs, such as the MicroGenie Program, sold by Beckman Instruments (Palo Alto, California). Present programs are limited in that only two sequences can be compared at a time and all nucleotides are given equal importance. A more complex comparison can be made, but a more powerful computer a Cray computer) is required. Waterman, M.S. Multiple Sequence Alignment by Consensus. Nuc.

Acids. Res. 14 (1986), 9095-9102. The preferred method for selection requires alignment of multiple sequences and the identification of conserved blocks. Probes are then chosen to irclude maximum diversity 4 'j r WO 89/06704 PCT/US89/00072 13 insertions or deletions instead of transitions). The probes may be either DNA or RNA, although DNA probes are preferred because they can be chemically synthesized.

The degree of complementarity (homology) required for detectable binding with the rRNA of pathogenic bacteria will vary in accordance with the stringency of the hybridization medium and/or wash medium. The degree of complementarity will optimally be 100 percent; however, it should be understood that minor variations in the rRNA may be compensated for by reducing the stringency of the hybridization and/or wash medium as described below. Thus, despite the lack of 100 percent complementarity under reduced conditions of stringency, functional probes having minor base differences from their rRNA targets are possible. Therefore, under hybridization conditions of reduced stringency, it may be possible to modify up to 60% of a given oligonucleotide probe while maintaining an acceptable degree of specificity. In addition, analogs of nucleosides may be substituted within the probe for naturally occurring nucleosides. This invention is intended to embrace these species when referring to polynucleic acid probes.

To obtain large quantities of DNA or RNA probes, one can either clone the desired sequence using traditional cloning methods, such as described in Maniatis, et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York, 1982, or one can produce the probes by chemical synthesis using commercially available DNA synthesizers. An example of cloning would involve insertion of the cDNA for the ribosomal RNA into a replication vector, such as pBR322, M13, or into a vector containing the SP6 promotor generation of single-stranded RNA using SP6 RNA polymerase), and transformation of a bacterial host. The DNA probes can be purified from the host cell by lysis and nucleic acid extraction, treatment with selected restriction enzymes, and further isolation by gel I i WO 89/06704 PCT/US89/00072 14 electrophoresis.

DNA probes may be chemically synthesized using commercially available methods and equipment. For example, the solid phase phosphoramidite method can be used to produce short probes of between 15 and 50 bases.

For this invention, it is preferred to chemically synthesize short DNA probes using the Model 380B DNA Synthesizer from Applied Biosystems, Foster City, California, using reagents supplied by the same company.

Probes may be comprised of the natural nucleotide bases or known analogs of the natural nucleotide bases, including those modified to bind labeling moieties.

The oligonucleotide sequences in Table 1 are representative of probes that hybridize with and detect specific regions of specific 16S rRNAs. The oligonucleotide sequences in Table 3 are representative of probes that hybridize with and detect hypervariable regions of specific 23S rRNAs, and should not be viewed as limiting. Probes may consist of these sequences or equivalent sequences, by themselves as a single unit for binding, or may be comprised of additional sequences not having the capacity to bind to non-pathogenic associated bacteria. Probes comprising more than the short sequences, as offered in Table 1, may have repeating units of the same sequence concatemers of a sequence), a mixture of different sequences specific to one species of bacteria, and even a mixture of sequences that may be specific to one or more bacterial species associated with oral diseases.

If such probes are to contain concatemers of short sequences, said long probes will display the high hybridization specificity inherent in a "short" probe containing, for example, only 20 nucleotides. This concatemeric probe sequence could be contained within the cloning vector sequences and would have the structure given by the formula below. Alternatively, the concatemer having the formula [X-Y-ZJn as previously defined i r It I (WO89/06704 PCT/US89/00072 could be excised from the cloning vector with the appropriate restriction endonuclease.

Probes may be labeled by any one of several methods typically used to detect the presence of hybrid polynucleotides. The most common method of detection is 3 125 35 14 the use of autoradiography with H, I, S, C, or 32 3P labeled probes or the like. The choice of radioactive isotope depends on research preferences due to ease of synthesis, stability and half lives of the selected isotopes. Other labels include ligands which bind to antibodies labeled with fluorophores, chemiluminescent agents, and enzyes. Alternatively, probes can be conjugated directly with labels such as fluorophores, chemiluminescent agents or enzymes. The choice of label depends on sensitivity required, ease of conjugation with the probe, stability requirements, and available instrumentation.

The choice of label dictates the manner in which the label is bound to the probe. Radioactive probes are typically made using commercially available nucleotides containing the desired radioactive isotope. The radioactive nucleotides can be incorporated into probes, for example, by using DNA synthesizers, by nick translation with DNA polymerase I, by tailing radioactive DNA bases to the 3' end of probes with terminal deoxynucleotidyl transferase, by treating single-stranded M13 plasmids having specific inserts with the Klenow fragment of DNA polymerase in the presence of radioactive deoxynucleotides, dNTP, by transcribing from RNA templates using reverse transcriptase in the presence of radioactive deoxynucleotides, dNTP, or by transcribing RNA from vectors containing specific RNA viral promoters SP6 promoter) using the corresponding RNA polymerase SP6 RNA polymerase) in the presence of radioactive ribonucleotides rNTP.

The probes can be labeled using radioactive nucleotides in which the isotope resides as a part of the I4 WO 89/06704 PCT/US89/00072 16 nucleotide molecule, or in which the radioactive component is attached to the nucleotide via a terminal hydroxyl group that has been esterified to a radioactive component such as inorganic acids, 32 P phosphate or 14 C organic acids, or esterified to provide a linking group to the label. Base analogs having nucleophilic linking groups, such as primary amino groups, can also be linked to a label.

Non-radioactive probes are often labeled by indirect means. For example, a ligand molecule is covalently bound to the probe. The ligand then binds to an anti-ligand molecule which is either inherently detectable or covalently bound to a detectable signal system, such as an enzyme, a fluorophore, or a chemiluminescent compound. Ligands and anti-ligands may be varied widely. Where a ligand has a natural anti-ligand, namely ligands such as biotin, thyroxine, and cortisol, it can be used in conjunction with its labeled, naturally occurring anti-ligands. Alternatively, any haptenic or antigenic compound can be used in combination with an antibody.

Probes can also be labeled by direct conjugation with a label. For example, cloned DNA probes have been coupled directly to horseradish peroxidase or alkaline phosphotase, (Renz. and K'Lrz, K. A Colorimetric Method for DNA Hybridization. Nuc. Acids Res. 12:3435- 3444, 1984) and synthetic olignucleotides have been coupled directly with alkaline phosphatase (Jablonski, et al., Preparation of Oligodeoxynucleotide-Alkaline Phosphaatase Conjugates and Their Use as Hybridization Probes. Nuc. Acids. Res. 14:6115-6128, 1986, and Li P., et al., Enzyme-linked Synthetic Oligonucleotide probes: Non-Radioactive Detection of Enterotoxigenic Escherichia Coli in Faeca Specimens. Nuc. Acids Res. 15:5275-5287 (1987).

Enzymes of interest as labels will primarily be hydrolases, such as phosphatases, esterases and glyco- 4 i: ,WO 89/06704 PCT/US89/00072 17 sidases, or oxidoreductases, particularly peroxidases.

Fluorescent compounds include fluorescein and its derivatives, rhodamine and its derivatives, dansyl, umbelliferone, etc. Chemiluminescers include luciferin, and 2,3-dihydrophthalazinediones, luminol.

Hybridization Conditions Various hybridization solutions may be employed, comprising from about 20 to 60% volume, preferably of a polar organic solvent. A common hybridization solution employs about 50% v/v formamide, about 0.5 to 1M sodium chloride, about 0.05 to 0.1M buffers, such as sodium citrate, Tris-HCl, PIPES or HEPES (pH range about about 0.05 to 0.2% detergent, such as sodium dodecylsulfate, or between 0.5-20mM EDTA, ficoll (about 300-500 kilodaltons), polyvinylpyrroliodone (about 250- 500 kdal), and serum albumin. Also included in the typical hybridization solution will be unlabeled carrier nucleic acids from about 0.1 to 5 mg/ml, fragmented nucleic DNA, calf thymus or salmon Fperm DNA, or yeast RNA, and optionally from about 0.5 to 2% wt./vol.

glycine. Other additives may also be included, such as volume exclusion agents which include a variety of polar water-soluble or swellable agents, such as polyethylene glycol, anionic polymers such as polyacrylate or polymethylacrylate, and anionic saccharidic polymers, such as dextran sulfate.

An alternative hybridization solution may be employed comprising about 2 to 4M GUSCN, preferably 3M, about 0.01 to 0.1M Tris (pH range about 6.0 to a detergent such as sodium dodecyl sulfate in concentrations of about 0.1 to 5% and about 0.01 to 0.1M EDTA. Other additives may also be included such as carrier DNA or RNA, or protein such as bovine serum albumin or gelatin. Stringency of the hybridization solution can be adjusted by the addition of about 0 to formamide, usually WO 89/06704 PCT/US89/00072 18 The particular hybridization technique is not essential to the invention. Hybridization techniques are generally described in Nucleic Acid Hybridization: A Practical Approach, Ed. Hames, B.D. and Higgins, S.J., IRL Press, 1987; Gall and Pardue (1969), Proc. Natl.

Acad. Sci., 63:378-383, and John, Burnsteil and Jones (1969) Nature, 223:582-587. As improvements are made in hybridization techniques, they can readily be applied. One such improvement is the subject of Serial No. 130,754, our docket 11652-5, filed on December 9, 1987, incorporated herein by reference, which relates to the use of ultrasonic energy to enhance the rate of hybridization. This is an optional step which does not influence the specificity of the probes described herein.

The amount of labeled probe which is present in the hybridization solution may vary widely, depending upon the nature of the label, the amount of the labeled probe which can reasonably bind to the cellular target nucleic acid, and the stringency of the hybridization medium. and/or wash medium. Generally, substantial excesses of probe over the stoichio etric amount of the target nucleic acid will be employed to enhance the rate of binding of the probe to the target DNA.

Various degrees of stringency of hybridization can be employed. As the conditions for hybridization become more severe, there must be a greater degree of complementarity between the probe and the target for duplex formation to occur. The degree of stringency can be controlled by temperature, ionic strength, pH and the presence of a partially denaturing solvent such as formamide. For example, the stringency of hybridization is conveniently varied by changing the polarity of the reactant solution through manipulation of the concentration of formamide within the range of 0% to Temperatures employed will normally be in the range of about 20° to 80°C, usually 30° to 75 0 C. For probes of 15-50 nucleo'tides in 50% formamide, the optimal temper- WO 89/06704 PCT/US89/00072 19 ature range can vary from 22* to 65"C. With routine experimentation, one can typically define conditions which permit satisfactory hybridization at room temperature, Assay test protocols for use in this invention are those of convention in the field of nucleic acid hybridization, and include both single phase, where the target and probe polynucleic acids are both in solution, and mixed phase hybridizations, where either the target or probe polynucleotides are fixed to an immobile support. The assay test protocols are varied and are not to be considered a limitation of th.. invention. A general review of single phase hybridization can be had from a reading of Nucleic Acid Hybridization: A Practical Approach, Ed. Hames, B.D. and Higgins, IRL Press, 1985, and Hybridization of Nucleic Acids Immobilized on solid Supports, Meinkoth, J. and Wah, Analytical Biochemistry, pp. 238, 267-284, 1984. Mixed phase hybridizations are preferred.

Cultured colonies of the bacteria can be assayed using colony hybridization techniques, wherein the bacteria suspected of being orally pathogenic are plated and adsorbed onto a filter prior to exposure to the target polynucleotides (Grunstein and Hogness, Colony Hybridization in Methods of Enzymology, Ed. Ray Wu, 1979, Vol. 68, pp. 379'409, and Proc. Natl. Acad. Sci. U.S.A., Vol. 72, No. 10:3961-3965, 1975). The colonies may also be identified by electrophoretically separating the nucleic acid and exposing the separated species to those S. 30 probes designed to distinguish between species of pathogenic oral bacteria. Ribosomal RNA may be detected using the methods of Alwine, et al., Proc. Natl.

Acad. Sci. Vol. 74(12): 5350-5354 (1977).

Techniques for the electrophoretic separation of DNA, including ribosomal genomic regions, are described in WO 83/01073.

i' 1 ii i .I L-C~~ WO 89/06704 PCT/US89/00072 Methods for in situ hybridization are also applicable to this invention. In situ hybridization refers to the identification of bacterial cells using polynucleotide probes, wherein the intact cell is immobilized and provided as a target. The following two rsview articles provide an overview of the art of in situ hybridization: Singer, et al., Biotechniques, 4(3):230-250 (1986), and Haase, Al, et al., Methods in Virology, Vol. VII, pp. 189-226 (1984), and are incorporated by reference herein.

Nucleic acids from GuSCN-lysed bacteria can be immobilized directly on to nitrocellulose or Nytran, and hybridized with the appropriate probe. The GuSCN-lysate is diluted with buffer containing formaldehyde, slotted to nitrocellulose and heated at 80"C to denature the nucleic acids.

Regardless of the assay test protocol being used, the bacterial cells are to remain in contact with a hybridization solution at a moderate temperature for an extended period of time. In single phase assays, the double-stranded duplexes may be separated from singlestranded nucleic acid by S 1 nuclease digestion followed by precipitation of duplex molecules, or by selective binding to hydroxyapatite. In mixed phase assays, the support-immobilized nucleic acids is introduced into a wash solution having analogous concentrations of sodium chloride, buffers, and detergent, as provided in the hybridization solution. The time period for which the support is maintained in the wash solution may vary from several minutes to three hours or more.

Either the hybridization or the wash medium can be stringent. Typically, for mixed phase assays, it is the wash solution that most often determines the stringency and facilitates dissociation of mismatched duplexes. After rinsing the support at room temperature with a dilute buffered sodium chloride solution, the support may now be assayed for the presence of duplexes S WO 89/06704 PCT/US89/00072 21 in accordance with the nature of the label.

Where the label is radioactive, the presence of probe carn be detected in a scintillation counter. More conveniently, in mixed phase assays, the substrate can be dried and exposed to X-ray film in any number of conventional autoradiographic protocols.

Where the label is fluorescent, the sample is detected by first irradiating it with light of a particular wavelength. The sample absorbs this light and then emits light of a different wavelength which is picked up by a detector (Physical Biochemistry, Freifelder, D., W.H. Freeman Co., pp. 537-542, 1982).

Where the label is a hapten or antigen, the sample can be detected by using antibodies. In these systems, a signal is generated by attaching fluorescent or enzyme molecules to the antibodies; in some cases the antibody is labeled with a radioactive probe. (Tijssen, Practice and Theory of Enzyme Immunoassays, Laboratory Techniques in Biochemistry and Molecular Biology, Burdon, van Knippenberg, Ph.H., Eds., Elsevier, pp. 9-20, 1985.) One method of detection is enzymatic detection in conjunction with biotin. Although fluorescence is an alternative label, enzymatic labels, in combination with avidin or streptavidin such as biotinylated peroxidase or alkaline phosphatase, are preferred. Enzyme-conjugated avidin or streptavidin can also be used to directly bind the enzyme to the probe (Haase, et al., supra).

Preferred enzymes are peroxidase or alkaline phosphatase.

An especially preferred method utilizes enzymes directly conjugated to probes. The preferred enzymes are alkaline phosphatase and peroxidase. Methods for conjugating enzymes to oligonucleotides e known. Nucleic Acid Res., 14:6115-6128 (1986) and Nucl. Acid Res., 15:5275- 5287 (1987).

The preferred assay protocol involves direct testing of samples without culturing. These protocols

A

WO 89/06704 PCT/US89/00072 22 demand additional sensitivity for which the invention has particular application. Samples suspected of containing oral pathogenic bacteria are first subjected to a lysing solution, such as a buffered solution of detergent and a divalent metal chelator or a buffered chaotrophic salt solution containing a detergent, a reducing agent and a divalent metal chelator. The sample may be directly fixed to a support or further processed to extract nucleic acids. Released or extracted bacterial nucleic acid (including target nucleic acid) are fixed to a solid support, such as cellulose, nylon, nitrocellulose, diazobenzyloxymethyl cellulose, and the like.

In the preferred instance, the assay protocol is a sandwich-type assay. A primary component of a sandwich-type assay is a solid support. The solid support has adsorbed to it or covalently coupled to it immobilized nucleic acid probe that is unlabeled and complementary to one portion of the rRNA sequence.

Preferred are those probes that hybridize to regions of the ribosomal RNA with minimal secondary and tertiary interactions, such as those listed in Table 4. The advantage of such probes is that the hybridization can be carried out without the additional step of heat denaturing the sample nucleic acid. The test sample suspected of containing oral pathogenic bacteria is then contacted with the solid support in a hybridization medium. Finally, a second soluble-labeled probe complementary to a different sequence of the rRNA of the pathogenic bacteria is hybridized to the rRNA that has formed a hybridization duplex with the immobilized nucleic acid probe on the solid support.

The presence of the bacteria is then determined in accordance with the label being used. It should be noted that the second probe can be added simultaneously with the test sample to the hybridization assay. In addition the second probe can hybridize to either a conserved or to a hypervariable region of the rRNA.

,WO 89/06704 PCT/US89/00072 23 i! Preferred are the probes derived from conserved regions of the ribosomal RNA with minimal secondary and tertiary interactions (Table such as UP7B or UP9A for 16S ribosomal RNA, and UP12B or 23UPB for 23S ribosomal RNA.

The advantage of such probes is that the hybridization can be carried out without the additional step of heat denaturing the nucleic acid. A general reference for various detection methods can be found in Hames, B.D. and Higgins, Nucleic Acid Hybridization, IRL Press, Oxford, 1985. References for sandwich assay with DNA probes are Dunn and Hassell Cell, Vol. 12, pp. 23-26, 1977, and Ranki, et al,, U.S, Patent No. 4,486,539.

The oligonucleotide or polynucleotide acid probes of this invention can be included in a kit which can be used to rapidly determine the presence or absence of oral pathogenic bacteria, especially the species disclosed in Table 1. The kit includes all components necessary to assay for the presence of these bacteria. Xn the universal concept, the kit includes a stable preparation of labeled probes to rRNA, hybridization .solution in eitzhsr dry or liquid form for the hybridization of target and probe polynucleotides, as well as a solution for washing and removing undesireable and nonduplexed polynucleotides, a substrate for detecting the labeled duplex, and optionally an instrument for the detection of the label.

A more specific embodiment of this invention embraces a kit that utilizes the concept of the sandwich assay. This kit would include a first component for the collection of samples from the mouths of patients, such as a scraping device or paper points, vials for containment, and buffers for the dispersement and lysis of the sample. A second component would include Media in either dry or liquid form for the hybridization of target and probe polynucleotides, as well as for the removal of undesireable and nonduplexed forms by washing. A third component includes a solid support upon which is fixed or tot I i; WO 89/06704 PCT/US89/00072 24 to which is conjugated unlabeled nucleic acid probe(s) that is(are) complementary to a part of either the 16S or 23S rRNA of the species of bacteria being tested. In the case of multiple target analysis more than one capture probe, each specific for its own ribosomal RNA, will be applied to different discrete regions of the dipstick.

A fourth component would contain labeled probe that is complementary to a second and different region of the same rRNA strand to which the immobilized, unlabeled nucleic acid probe of the third component is hybridized.

The probe components described herein include combinations of probes in dry form, such as lyophylized nucleic acid or in precipitated form, such as alcohol precipitated nucleic acid or in buffered solutions. The label may be any of the labels described above. For example, the probe can be biotinylated using conventional means and the presence of a biotinylated probe can be detected by adding avidin conjugated to an enzyme, such as horseradish peroxidase, which can then be contacted with a substrate which, when reacted with peroxidase,'can be monitored visually or by instrumentation using by a colorimeter or spectrophotometer. This labeling method and other enzyme-type labels have the advantage of being economical, highly sensitive, and relatively safe compared to radioactive labeling methods. The various reagents for the detection of labeed probes and other miscellaneous materials for the kit, such as instruotions, positive and negative controls, and containers for conducting, mixing, and reacting the various components, would complete the assay kit.

The following examples are offered by way of illustration and not by limitation.

SExample 1 A. Preparation of rRNA Bacterial cells are resuspended in a lysis solution (20 mg/ml lysozyme, 25% sucrose, 50mM Tris, pH IWO 89/06704 PCT/US89/00072 8, l0mM EDTA), and incubated at 37*C for 30 min. Sodium dodecylsulfate w/v) and pronzse E (1 mg/mi) or proteinase K (200 Aug/mj) are added, an~d the solution is incubated 30 min at 37 0 C. The lysates are extracted twice with phenoi:chloroform 1, v/v) and then precipitated with ethanol. Nucleic acid is pelleted, 4washed with 70% v/v ethanol, and resuspended to approximately 1 .,ng/ml tii 1X TE buffer, (2,0mM Tcis, pH 8 1mTM EDTA). Fesuspendad nucleic acid is stored at -70 0

C.

B. Oligonucleotide Sp~qjencing Primers Universal sequencing primers (UP) for rRNA were as dscribed Lat_ et al. Proc. Natl. Acad. Sci.

UL.S.P 8,95-6959 (1985). Three additional primers, harein designated UP4B, UP8B and tJP6B, and having the sequences tJP4 B: GCTGGCACGGAGTTAGCCG; UP8B: CACGARCTGACGACARCCATGC; UP6B: TACGGNTACCTTGTTAcGAC; were designed and utilized for sequencing.

C. Sequencing Reactions The protocol for sequencing is a modification of the dideoxynvclIetide -terinated chain elongated method described by Sanger, Ft, et Ll., Natl,. Acad. Scl.

74, 5463-5467 (1977), as adapted for rRNA 415 templates by Lane, et al. Pron;. Natl. Acad. Sci. U.S.A., 820 695t-9$9 (1935.. sequencing primers were radioactive' y labeed,. with 32P-ATP using T4 poly~nucleotide kinase (5OuCi 3ZP-ATP, 3000Ci/mMol, pler 300 ng oligo and 10 units of kinase) The radioactively labeled p~cinzers were ethanol, preoipitatted and rv7'uspanded in water to 3Ong/ml.

fol~lows. Two AlJ of primer are added to 3 pl of a solu-' tioh of bacterial nucleic acid 5-25 mg/mI), 2 AlJ F.Yt buffer (500mM ?XCI, 250mM Tris-IICj,, pH and 3 141 WO 89/06704 PCT/US89/00072 26 of H 2 0. The mix is heated at 100°C for 2 min, then cooled to room temperature. To this mix is added 4 p1 of RT buffer (250mM Tris-Hcl, pH 8.3, 250mM KC1, dithiothreitol, 50mM MgC12), 5 .l H 2 0, and 2 pl reverse transcriptase (200 U/pl, Bethesda Research Laboratories, Gaithersburg, Maryland). Three p1 aliquots are pipetted into 2 p1 deoxynucleotide/dideoxynucleotide mixes 17 pM dATP, 300 pM dCTP, 330 AM dGTP, 330 pM TTP, 125 pM ddATP; C: 330 pM dATP, 17 pM dCTP, 330um dGTP, 330 pM TTP, 125 pM ddCTP; G: 330 pM dJ.TP, 330 pM dCTP, 17 pM dGTP, 330 pM TTP, 250 pM ddGTP; T! 330 pM dATP, 330 pM dCTP, 330 pM dGTP, 17 M TTP, 125 pM ddTTP). The reactions are incubated at 43°C for 15 min. Two p1 of chase (330 pM dATP, dCTP, dGTP, TTP, plus 400 units of reverse transcriptase) are added to each reaction. The reactions are incubated for an additional 15 min at 43°C, and terminated by the addition of 6 pA loading solution formamide, 2.5% xylene cyanol, 2.5% bromphenol blue). Reaction products were electrophoresed on 8% 'polyacrylamide denaturing gels and visualized by autoradiography. The sequencing reactions can also be performed using unlabeled sequencing primer and under reaction conditions similar to those described above.

D. Synthesis and Purification of Synthetic Oligonucleotide Probes Oligonucleotides were synthesized on an Applied Biosystems DNA synthesizer Model 380B via 6-cyanoethylphosphoramidite chemistry. The oligonucleotides were purified by preparative polyacrylamide gel electrophoresis or by high pressure liquid chromatography and eluted as detailed in Applied Biosystems User Bulletin No. 13; "Evaluationv and Purification of Synthetic Oligonucleotides," November 9, 1984. See table 1 for preferred sequences.

v i ;T t, WO 89/06704 ,r PCT/US89/00072 27 E. Isolation of Nucleic Acid from Bacterial Culture or Subqingival Plaque Samples The following procedure is applicable to either a curette scraping or cultured bacteria: 500 ~l of sample (stored at -70°C) is thawed with the following steps to be conducted immediately. 100 ng of an unrelated carrier oligonucleotide (24 bases) is added to the sample if it is a plaque sample or a dilute bacterial sample. 250 pl of sucrose lysis buffer (75% (w/v) sterile sucrose, 10mM EDTA, 10mM EGTA, 50mM Tris-HCl (pH is added to the sample and vortexed briefly. 50 ul of freshly made lysozyme (10 mg/ml in 0.25X bacterial sucrose lysis buffer; Sigma Chemical), is added and the sample incubated for 15 min at 37°C. 75 pl of 10% SDS is then added and the sample vortexed briefly. 75 il of Pronase E (10 mg/ml, Sijma Chemical; self-digested as per Maniatis, et al., Molecular Cloning: A Laboratory Manual) is added, the sample vortexed briefly anid incubated at 37°C for 30 min. The sample is extracted two t'imes with phenol:chloroform:isoamyl alcohol (24:24:.1, v/v/v), saving the aqueous phase. If the interphase is not clear, it can be extracted again with chloroform and the aqueous phase saved. The sample is then concentrated by lyophilization to 300 AI, to which 150 Al of a sterile 7.5M NH OAc solution is added, and followed by 1.12 ml of ethanol. The sample is then mixed and stored at for 30 min or longer to precipitate the nucleic acid, and the pellet is recovered by centrifugation for min at 4°C. The nucleic acid pellet is washed once with 1.5 ml of 95% ethanol, dried briefly, and then resuspended in 400 gl of sterile TE buffer (10mM Tris-HCl pH 7.5, O.ImM EDTA).

F.a) Immobilization of Nucleic Acid onto Nvtran Membranes The extracted microbial nucleic acids are immobilized onto Nytran as follows: 380 Al of nucleic

J

I;i B:iI

J

i i L WO 89/06704 PCT/US89/00072 28 acid (at less than 6 Ag/380 Al) in TE and 20 Al of 200mM Pipes (pH 7.42) are mixed to give a final concentration of 20mM Pipes. The sample is heated to 100 0 C for 90 sec, quickly chilled in a ice/water bath, and then applied to a Nytran membrane using a slot blot apparatus from Schleicher and Schuell (Keene, New Hampshire). Slotting should be finished within 20 min of the heat treatment.

The slots are washed with 200 pl of 10X SSC (1.5M NaC1, 0.15M sodium citrate pH the Nytran membrane with immobilized nucleic acid baked at 80 0 C for 1 hour, and the Nytran membrane stored at room temperature between blotting paper.

F.b) Direct immobilization of cell lysates to nitrocellulose membranes A cell pellet of cultured bacteria or a plaque sample is resuspended in 100ul of 3M GUSCN, 2% sarkosyl w/v, 50mM Tris-HCl (pH 10mM EDTA,and 1% v/v mercaptoethanol and incubated at room temperature for min. To this solution is added 0.3 volumes of 20X SSC, followed by 0.2 volumes of 37% formaldehyde, and incubation at 55°C for 15 min. Serial dilutions are made in 15X SSC and the nucleic acid solutions slotted onto nitrocellulose (prewetted with water and soaked in 6X SSC for 10 min). The filters are baked at 80°C under vacuum for 2 hours and stored at room temperature between blotting paper.

G. Hybridization Procedure A Probes are labeled with 3 2 P by polynucleotide kinase as per Maniatis, T. et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York, 1982, (200 ng of oligonucleotide, 60 Ci 32P-ATP, and 40 units of T 4 polynucleotide kinase in a 25 ~l volume) and purified by ethanol precipitation and Elutip-D chromatography (Scheicher and Schuell). Alternatively, 4 WO 89/06704 PCT/US89/00072 29 probes are synthesized with an ethylamine group at the end, biotinylated with NHS-LC-biotin (Pierce Chemical Co., Rockford, Illinois), and purified by Elutip-D chromatography. Nucleic acids, immobilized on Nytran or nitrocellulose membranes, are hybridized with 5 ng/ml of oligonucleotide probe in 0.6M NaCl, 90mM Tris-HC:' (pH 10mM EDTA, 5X Denhardt's solution, 30% deionized formamide, 0.1% SDS, and 100 Al/ml fragmented yeast RNA at 42°C, or in 0.9M NaCl, 90mM Tris-HCl (pH EDTA, 5X Denhardt's solution, 0.1% SDS, and 100 gg/ml fragmented yeast RNA at 50°C. The hybridizations are carried out in 50 ml polypropylene tubes or with sealed "Micro-Seal" plastic bags (Dazey Corp., Industrial Airport, Kansas) on a rotary shaker at the appropriate temperature for 1 hour or longer. The membranes are first washed in 0.09M NaCl, 9mM Tris-HCl (pH 1mM EDTA, and 0.1% SDS at room temperature, and then washed in the same wash buffer at 50°C (=stringent wash). An alternate stringent wash can be conducted with 3.1M tetraethylammonium bromide, 50mM Tris-HCl (pH 2mM EDTA, and 0.1% SDS at 29°C (this procedure requires a 0.9M NaCI, 90mM Tris-HCl (pH 10mM EDTA pre-wash prior to the tetraethylammonium bromide wash).

Procedure B Nucleic acids immobilized on membranes are hybridized with 5ng/ml oligonucleotide probe in 3M GuSCN, formamide, 50mM Tris(pH 10mM EDTA, 2% sarkosyl for 0.5 to 24 hours as described in procedure A. The membrane is washed twice for 2 min with a solution containing 0.09M NaCl, 9mM Tris-HCl (pH 1mM EDTA, and 0,1% SDS at room temperature. When 32 P labeled probes were used, nucleic acids were visualized by autoradiography. The use of biotinylated probes required the incubation with streptavidine-alkaline phosphatase or streptavidine-peroxidase followed by color development as described in Example 2.

WO 89/06704 PCT/US89/00072 H. Detection of Hybridized Probe Hybridized probe labelled with P3 was detected by autoradiography. Biotinylated probes were detected by the Detek-alk kit (avidin-alkaline phosphatase; Enzo Biochem, New York, New York) or the DNA detection kit (streptavidin/biotinylated alkaline phosphatase polymer; Bethesda Research Labs, Gaithersburg, Maryland).

I. Identification of Synthetic Oliqonucleotide Probes Complementary to regions with minimal secondary and tertiary interaction The chemical and enzymatic accessibility of nucleotides along the predicted secondary structure of the 16S and 23S ribosomal RNA have been observed. Moazed, D. et al. (1986) J. Mol. Biol. 187:399-416. Noller, H.F.

et al. (1981) Nucleic Acids Res. 9:6167-6189. However, the accessibility of these regions to complementary oligonucleotide probes is not predictable. Lasater, L.S.

et al. (1988) Biochemistry 28:4687-4695. Regions of the j ribosomal .RNA with minimal secondary and 'tertiary interactions are defined by solution hybridization and sandwich assay methods. For example, purified ribosomal RNA (1-5 ug) was hybridized with 3 P-labelled complementary oligonucleotide probes (5-10 ng), such as those in Table 1 or Table 2, in 0.09M NaC1, 9mM Tris-HCl (pH and ImM EDTA, or 3M GuSCN, 2% sarkosyl, Tris-HC1 (pH 10mM EDTA, 1% mercaptoethanol, and formamide.

Following hybridization for 15 min to 1 hour, the sample was subjected to agarose gel electrophoresis to 4 30 separate the 16S and 23S ribosomal RNA subunits, and the oligonucleotide probe:rRNA hybrids visualized by autoradiography. Oligonucleotide probes which showed hybridization specific to their respective ribosomal RNA subunit were further tested in the sandwich assay format.

In this format the test oligonucleotide probe was covalently attached to a solid support. Target ribosomal WO 89/06704 PCT/US89/00072 31 RNA was hybridized in the presence of the test oligonucleotide and 3P-labelled signal oligonucleotide probes, such as UP7B or UP9A for 16S ribosomal RNA, or UP12B or 23UPB for 23S ribosomal RNA, using the GuSCN hybridization solution described above in Procedure B.

After hybridization for 2-15 hours, the solid support was washed of unhybridized nucleic acid, and the amount of ribosomal RNA captured by the test oligonucleotide probe quantitated by liquid scintillation counting.

Example 2 The direct conjugation of alkaline phosphatase to the oligonucleotide probes will eliminate several steps required in the assay procedures using oligonucleotide probes biotinylated probes) which are indirectly linked with enzymes.

Direct conjugation of alkaline phosphatase to a short probe involves conjugation via heterobifunctional 'reagents. The synthetic probe is synthesized as described herein with a linker arm reagent attached to the terminal An aminohexyl linker arm with a terminal amino group is attached to the 5'-hydroxyl of the synthetic oligodeoxynucleotide as the last step in its synthesis on an automated DNA synthesizer. The reagent used for linker arm introduction is 6-(methoxytritylamino)hexyl 2cyanoethyl N,N-diisopropylphosphoramidite, prepared from 6-aminohexanol in a manner similar to the synthesis of the 3-(methoxytritylamino)propyl methyl N,N-diisopropylphosphoramidite, as described by B.A. Connolly, Nucl.

Acids Res., 15:3131 (1987). The linker arm is attached to the probe, and the deprotected probe purified in a method similar to the methods described in the Connolly reference.

The oligonucleotide first is derivatized with the thiol-reactive agent N-succinimidyl(4-iodoacetyl)aminobenzoate ("SIAB") through the amino linker arm, The I i WO 89/06704 PCT/US89/00072 32 SIAB-oligonucleotide is prepared by adding 1.2 mg SIAB to 300 pg of the oligonucleotide, incubating for one hour at room temperature, and desalting over a G-25 column equilibrated with 20mM sodium phosphate (pH EDTA. This probe derivative can be coupled to alkaline phosphatase which is modified as described below.

Alkaline phosphatase is thiolated with dithiobis(succinimidylpropionate) by adding 800 Ag DSP to 4 mg alkaline phosphata se. The reaction is allowed to proceed for 30 min at room temperature. The reaction mixture then is treated with dithiothreitol for 15 min at room temperature to reduce the disulfide, and desalted over a G-25 column equilibrated with 20mM sodium phosphate (pH The SIAB-oligonucleotide is mixed with the DSPalkaline phosphatase at a oligonucleotide:alkaline phosphatase ratio of 4:1. 5M NaCl is added to the reaction to bring the final NaCl concentration to 3M, and the pH is adjusted to 7.5 with 0.1 volume IM Tris (pH The coupling reaction is allowed to proceed overnight (16 hours), then stopped with N-ethylmaleimide (2 Al of lOng/ml). The conjugate is separated from free oligonucleotide by gel filtration on a P-100 column, and free alkaline phosphatase is removed by DEAE cellulose chromatography.

Horseradish peroxidase (HRP) is first treated with NaIO 4 (104:HRP, 160:1) to oxidize the sugar diols.

After 15 min at room temperature the 0 4 is removed by gel filtration over Sephadex G-25, and the material concentrated to less than 20 mg/ml in 1mM NaOAc (pH The concentrated HRP is then used to resuspend a pellet of oligonucleotide with a 5'-hexylaminelinker arm.

Following resuspension, the pH of the reaction mix is adjusted to 9.5 with carbonate buffer and NaBH3CN is added to 50mM. The reaction is allowed to proceed for 16 to 20 hours at room temperature and the products separated by HPLC using a GF-250 column (Dupont). The h 4 7 WO 89/06704 PCT/US89/00072 33 probe-enzyme conjugates are tested in the following ways.

*1 Fusobacterium nucleatum or Bacteroides gingivalis genomic DNA was serially diluted into human placental DNA, heat denatured, and applied to slots on a Nytran membrane.

Bg-lB:HRP (100 ng/ml in 30% formamide, 0.6M NaCl, t'ris-HCl (pH 10mM EDTA, and 0.1% SDS) was hybridized to the immobilized DNA for 1 hour at room temperature, and washed in 0.45M NaCl, 45mM Tris-HCl pH 5mM EDTA pH 8.0, and 0.1% SDS for 20 min at The wash solution was removed, and substrate solution (100mM HEPES Citrate-phosphate buffer (pH 90pM 3methyl-2-benzothiazolinone hydrazone, 6mM 4methoxynaphthol, and 4mM H02, or 19mM 9-aminoethylcarbazol, 100mM NaOAc pH 4.5, and 7mM H 2 0 2 was added. Hybridized probe was detected as a blue or brown precipitate, respectively, on the Bacteroides gingivalis DNA slots.

Fn-lB:alkaline phosphatase or Bg-lB:alkaline phosphatase were hybridized for 1 hour at room temperature to the Nytran membranes as above. The membranes were washed as above and substrate solution (0.6mM nitroblue tetrazolium in 70% dimethylformamide, 0.6mM 4-chloro-3-indolyl phosphate in 0.1M Tris-HCl pH 0.1M NaC1, 50mM MgCl 2 was added. Hybridized probe was detected as a blue precipitate on F. nucleatum or B.

gingivalis DNA slots, respectively.

Sandwich hybridizations with the Bg-lB:HRP probe was performed as follows. Varying concentrations of Bgprobe in PBS (150mM NaCl, 10mM sodium phosphate pH 7.01) were immobilized to cysteamine-derivatized Pall Immunoaffinity membranes (Pall Corporation, East Hills, The membranes were made by conjugating Pall Immunoaffinity membranes (0.2 p pore size) with cystamine in PBS and then washing and treating the cystamine-derivatized membranes with DTT (10mM for 30 min at 25"C) to produce a cysteamine-derivatized membrane.

Non-covalently immobilized probe was removed from these I

'I

WO 89/06704 PCT/US89/00072- 34 membranes by heating at 90*C in PBS. The membraftes were hybridized with a DNA target (complementary to Bg-5B) and Bg-lB:HRP(BgiB: CGG 31) for 30 min in 0.6M NaCl, 30% formamide, Tris-HCi (pH 10mM EDTA, 0.1% SDS at 42*C. The complex was washed in 0.09M NaCi, 9mM Tris (pH 1mM EDTA at 50*C for 20 min. The wash solution was decanted and the 4-chloro-methoxynapthol substrate added. After a 15 min incubation, at room temperature, the hybridized Bg-lB:HRP probe was detected as a blue precipitate on the membrane. Purified Bg 2,6S rRNA hybridized in a like manner also was detected by sandwich hybridization with Bg-lB:HRP and Example 3 Different concentrations of B. gingivalis were lysed with 3M GuSCN, 5% formamide, 50mM Tris-HCl (phi 10 mM EDTA, 2% sarkosyl, and 1% mercaptoethanol.

Pall membranes with 0.1 gg of 'imnmobilized oligonucleotide were immersed into the lysate and~ hybridized for 0.5 to Z~4 hours at room~ temperature. The membranes were washed with a solution containing 0. 09M NaCl, 9 mM Tris-HC. (PH 1mM EDTA, and SDS. The membranes were hybridized again in the GuSCNU/formamide lysis solution containing 10-10ong/ml biotinylated signal oligonucleotide and hybridized from to 24 hours. The biotinylated signal oligonucleotides used were UP7B, UP9A, and UP3A. The membranes were washed with a soltition containing 0.09 m NaCi 9 mM Tris-'dCl (phI 8. 1mM EDTA, and 0. SDS. The membranes were then icubated with the strepavidin conjugate o~f alkaline phosphatase (or horse-radish peroxidase) in 0.18M4 NaCl, 3,81nM Tris-HC. (phI 2mM EDTA, 0.5% SDS, and 0.1% gelatin at room temperature for 15 to 60 min. After the incubationv the mnembranes were washed three times for 1 min each With 0.18M4 NaCl, 18mM S WO 89/06704 PCT/US89/00072 Tris-HC (pH 2mM EDTA, and 0.5% SDS, then two times for 1 min each with 0.18M NaCI, 18mM Tris-HCl (pH and 2mM EDTA, and finally once with appropriate substrate buffer. Color was developed for the two enzymes as described in Example 2. The hybridized signal prcbe was detected as brown and blue spots for alkaline phosphatase and horse radish peroxidase, respectively. Depending on the enzyme and hybridization conditions, detection of -xl0 7 B. gingivalis cells was observed. Signal intensity is dependent upon the number of bibtinylated signal oligonucleotides used, and is 3X less when only one signal oligonucleotide is present in the assay.

Example 4 A test kit for the detection of oral pathogenic bacteria will contai all of the required components for the collection, processing, and evaluation of several samples, as well as the associated instructions and patient data collection cards.

Product Insert. The Product Insert will contain complete written instructions for patient sampling and evaluation.

The instructions will follow the procedures of Example 3.

Data Card. A Data Card will be included for the recording of minimal baseline data for each patient, such as patient identification, site of collection, and test results.

4 currettes, Currettes for sampling by scraping.

Endodontic Points. Endodontic points (paper points) for collection of each sample to be tested are also included.

After cleansing the sapragingival surfaces by wiping with gauze, the point will be used to rub the bacteria from the subgingival surface of the tooth to be sampled and to i4 WO 89/06704 PCT/US89/00072 36 collect bacteria by absorption of saliva, gingival fluid, and gingival plaque.

Lysing Reagent. Each point with the collected sample will be placed immediately into a numbered tube of Lysing Reagent which will lyse the bacteria and release the bacterial nucleic acids.

Probe/Enzyme Reagent. A standard aliquot of Probe labeled by a ligand with or directly conjugated to an Enzyme Reagent is added to each tube of Lysing Reagent to initiate the hybridization reaction between the pathogen nucleic acid targets and the signal oligonucleotide probes derived from conserved regions of the ribosomal RNA sequences.

Dipstick Device. An individual Dipstick Device containing site(s) with pathogen-specific DNA probes covalently immobilized to the solid support and having space for marking and identifying each site tooth sampled, is inserted immediately into each tube containing the hybridization mixture and incubated at room temperature.

Wash Reagent. Each Dipstick Device is removed from the hybridization mixture and washed with the Wash Reagent, using the bottle provided.

Enzyme Substrate Reagent. The Dipstick Devices are placed collectively into the Enzyme Substrate Reagent bottle and developed for several minutes to 1 hour at room temperature. Each Dipstick Device is washed again with the Wash Reagent to remove excess bakground color.

Reference Card. Color developmnt is visualized and compared with a Reference Card, indicating the pathogens providing a positive signal.

WO 89/06704 37 Table 1. Oligoriucleotides specific associated with periodontal disease.

P CT/U S89/00 07 2 for bacteria Oligonucleotide Primers Used to Derive Sequience Bacteroides ainaivalis Bg-lB Bg-4B Bg-6B Bg-3B Bg-8B Bg-7B 5 'CAATACTCGTATCGCCCGTTATTC3' 5' GTATAAAAGAAGTTTAMAATCCTT3' 5;CCTTA GGACAGTCTTCCTTCACGC31 50'CTGITGGAAGCTTGACGGTATATCG3' 5?GGTTTTCACCATCAGTCATCTACA31 5 'ATTACCCTAGTGCGCCCCTTGCGG3' 5'1CCGATGCTTATTCTTACGGTACAT31 UP4B/lB UP4 B/lB UP4 B/lB UP2 B UP8B UP GB UP4B/lB Actinobacillu-, (ex. Harixnophilus) actinomycetemcotnitans Aa-3B 5 'ATTTAACGTCAATTTGGCATGCTA3' Aa-2B 5 'CTTCGGGCACYAGGGCTAAACCCC3' Aa-4B 5 'ACCCATCTCTGAGTTCTTCTTCGG3' 5 'GTGGTAAACGCCCCCCTCTCGGTT3' Aa-IOB 5 'TGGCATGCTATTAACACACCAACC3' Bacteroides interrnedius Type I B4 -2B 5!GGTCCTTATTCGAAGGOTAAATGC3' BI -3B 5 'CACGTGCCCCACTTTACTCCCCAA3' Bi-6B 5 'TAGCCGCTAACGCCAGGCGCTAAC3' Bj-2B 5 'CCCTAGGYGCGCTCCTCGCGGTTA3' 506(AGTCAACATCTCTGTATCCTGCG3' 'TT~cCCTAGGTCGCTCCTCGCGGT3' Designed to hybridize to both Zrype Ove-rlaps with BJ,-2B Bacteroides intermedius,- Type 11 28i-3B 5 'AGACGCCCCGAAGGA.AGCCTATGT3' 2Bi-1B 5 'ATGAGGTQACATGCAATGGCGCACA3' 2Bi-2B 5 'CGTGCGCCAATTTAT2TCCCACATA3' UP4 B/lB UP2 B UP8 B UP6B UP413/lB UP41B/I B UP4 B/ J.B UP2B

UPGF$

UP8 B UP6B I and TI I Note UP8B UP4 B UP4 B I Bacteraides- forsythtis Bf -lB Bf-2B Bf -5B Bf -6B Bf-3B Bf -4B 5' CACAAGGTACATGCAATAAAATAC31 5' CGTATCTCAT'VTTATTCCCCTGTA30 5 'AGCTCTCACTCTCCGTCGTCTACA3' 5 'AATACACGTATCTCATTTTATTCC3$ 5 'GAAOAAAGCTCTCACTCTCCGTCG31 5' CTGTAGAGCTTACACTATATCGCA31 UP4 B UP4 B UP4 B LIN B UP8 B UP2 B WO 89/06704 WO 8906704PCT/US89/00072 38 Eikenella corrodens Eik-4B 5 'GTACGCTACTAAGCAATCAAGTTG3! Eik-1B 5 'TTAGGTACCGTCAGCAAAAAGTGG3' Eik-2B 5 'GCACTTCCCTTTTCTTCCCTAACA3' Eik-3B 5'TACCGTGGCAAGCGGGCTCCTTGC3' 5 'CTTCCGTCTCTGGAAGGTTCCGTAC3' Fusobacterium nucleatum/periodioxv Fri-lB 5 'GTCATCGTGCACACAGAATTGCTG3' .0 Fn-2B 5 'GTTGGTACCGTCATTTTTTTCTTC3' Fn-3B 5 'AGGTTTCCCCGAAGGCACTGAAAIC3' Fn-4B SiTCAGACTCTCGGTCOATTGTCCAA3' Fn-6B 5 'AAACATCTCTGTCTCATTCCTAAG3' Wolinella recta UP2B UP4 B UP4 UP6B UP8 B UP7B UP4B UP8 B JP4 B/lIB UP8B UP4 B UP6B UP2 B UP413 Wr-3,B Wr-2fl Wr-3B Wr-6B 5I'TACCGTCATAATTCTTTCCCAAG3' 5 'GGACCATAACCGGTTTGGTATTTG31 5 'GCATTACTGCCTCGACTAGCGAAG31 S 'CTTGGGTACCGTCATAATTCTTTCC31 Streptococcus intermedius Si-IB Si-2B SJ,-313 5' GTACCGTCACAGTATGAACTTTCC31 5 'TTCTCACACTCGTTCTTCCTIWAC3' 5 qLTTTCCATTCTCACCTCGTTCTTC31 tJP4 B tJP4 B UP4 B

I

I'

i WO 89/06704 WO 8906704PCT/US89/00072 39 Taole 2. Universal Primers for Sequencing and Conserved S~iqnal Oligonucleotides.

16S rRNA olicgonucleotide probes E. coli base nosition UP1B3* UP4 B 23P7B UP2B* UP2 D !JP2A UP3B* UP3A UP9A JP2 1A SI GWATTACCGCGGCKGCTG31 5 'GCTGGCACGGAGTTAGCCG31 5' GTATTACCGCGGCTGCTG31 S 'CCGTCAATTCATTTAAGTTT3' 5' CCCGTCWATTCMTTTGAGTTTT3' 5' CCCGtCAATTCATTTGAGTTTT3' 5'1kMGOCCGGTGTGTRC3f 5' TGACGGG'CGGTGTGTACAA3' 5' CTGCITGCCTCCCGTAGGAGT3' 5'1 GGGTATCT kATCCKGTTYGCTCC3' 5' GACTACYMGGGTATCTAATCC3' 5 1 TTAACCACATGYTCCWCCGCTTG3' 519-536 504 -522 519-536 907-926 9 06-927 9 06-927 1392-1406 1390-1408 338-357 77 5-79 7 785-805 936~-959 C rRNA oligonucleotide probes E. coli base Dosition UP12B UP1 3RB 23UPA 23UPB 2 3UPC 2 3UPD 23UPE 23UPF 215 23UPG 2-3 UPH 23UJPJ 2 3UPM 5 'TYCATTGGCMTTTCACCCC3' 51(1'%GGTTCTTTTCGCCTTTCC3 I 5 CTTAGATGCTTTCAGC31 5 'CCGGTCCTCTCGTACTA3' 5 'GGACCGAACTGTCTCACGAQGTTCT31 5' GACCGCCCCAGTCAAACT31 5'1CCCGACAAGGAATTTCGC03' 5'1CCTTCTCCCGAAGTTACGG3' 51GACCAGTGAGCTATTACGC3" 5' TTCGGOZGAGAACCAGCTA3t 51 TTC0CTCGCCGCTACT31 50IGTTAIAGTTACGGCCGCCGTTTAC3' 77 5-7 93 468-487 2744-2759 2653-2669 25387-2 611 2241-2258 1933-1950 1685-1703 1091-1109 803-820 241-256 1897-1920 *Ecjtivalent to ribosoi 41 RNA sequencing primers described by Lane et al.

4 WO 89/06704 PCTr/US89/000-2 Table 3. Bacteria specific Oligonucleotide Probes Dez:ived from 23S Ribosomal RNA Sequences.

Oligoriucleotide Primers Used to Bacteroidgs cfincivalis Derive Seqruence Bg23-l Bg2 3-2 Bg23-3 Bg23-4 Bg23-5 Bg23-6 5' TTGGAGCCGGTTTACATCCTTAT3' 5' GTACGGGTAAC2ACAGAAATATGCT3' 5 'CTCAAATTGCTTTTTTGATAGCTT3' 5' GACTATATACCTCAAATTGCTTTT3' 5' TTCTCTTGACGATGACTCCTCCTC3' 5' CCTACACATCTGATGCCAAATACA3' 23UPF 23UPF 23UPE 23UPE 23UPE 23UPD Fusobacterium nucleatum Fn23-1 5 'TCGATTAAGACTCCATCTTAATAG31 23UPJ b Ii 'Ii ii 4 4 f, WO089/06704 PCT/US89/00072 41 Table 4. Probes Derived from Hypervariable and Conserved Regions of the 16S and 23S Ribosomal RNA which are Free of Secondary and Tertiary Interactions.

Olicqonucleotide probe E. cola. base position 16S rRNA Hypervariable Regions Aa-4B Aa- 10 B Bg-6 B Bg-8B Bg-5B Bi-3B 2 Bi-2 B Eik-4B Eik-2B Fn-2B Fn-4B Fn-6B Wr-1B Wr-6B S 'ACCCATCTCTGAGTTCTTCTTCGG3' S 'TGGCATGCTATTAACACACCAACC31 51CCTTAGGACAGTCTTCCTTCACGC31 5 'GGTTTTCACCATCAGTCATCTACA31 S 'CCGATGCTTATTCTTACGGTACAT3' 5' CACGTGCCCCACTTTACTCCCCAA31 S 'GAGTCAACATCTCTGTATCCTGCG3' S 'CGTGCGCCAATTTATTCCCACATA31 5' GTACGCTACTAAGCAATCAAGTTG3' 5 'GCACTTCCCTTTTCTTCCCTAACA3' 5 'CTTCCGTCTCTGGAAGGTTCCGTAC31 S 'GTTGGTACCGTCATTTTTTTCTTC31 5' TCAGACTCTCGGTCCATTGTCCAA3' 5'1 AAACATCTCTGTCTCATTCCTAAG3 I S 'GTACCGTCATAATTCTTTCCCAAG3' f 'CTTGGGTACCGTCATAATTCTTTCC3' 990-1030 44 5-47 3 95-43 0 990-1030 47 5-5 44 5-4 990-1030 44 5-4 82 8-8 44 5-475 990-1030 44 5-4 44 5-475 990-1030I 44 5-47 44 5-47 23S rRNA Hypervariable Regions Bg2 3-2 Bg2 3-4 Bg23-6 5' GTACGGGTAACACAGAAATATGCT31 5' GACTATATACCTCAAATTGCTTTT30 5' CCTACACATCTGATGCCAAATACA31 1~570-1620 i800-1830 2085-2120 16S rRNA Conserved Regions8 UP2 D UP3A UP7B UP9A UP2 1A 5 'CCCGTCWATTCMTTTGAGTTTT3' 5' TGACGGGCGGTGTGTACAA3t 5 'GTATTACCGCGGCTGCTG31 5 'CTGCTGCCTCCCGTAGGAGT3' 5 'GACTACYMGGGTATCTAATCC3' 5 'TTAAACCACATGYTCCWCCGCTTG3$ 90 6-92 7 139 0-14 08 519-53 6 338-357 78 5-8 936-959 23S rRNA Conserved Regions UP12B 23UPB 2 3UPJ 23UPM 5 'TYGATTGGCMTTTCACCCC30 5 'CCGGTCCTCTCGTACTA3' 5 'TTCGCTCGCCGCTACT3' 5' GTTATAGTTACGGCCGCCGTTTAC31 775-79 3 2653-2669 24 1-256 1897-i920

Claims (21)

1. A composition Of polynucleotide probes for the detection of bacteria associated with a human oral medical Adisorder, wherein said probes comprise a selective sequence of to 100 nucleotides or nucleotide analogs capable of selectively hybridizing, under hybridizing conditions, to hypervariable regions of ribosomal RNA of the bacteria with the provision that any additional nuoleotides covalently bound to said /jQ=r~ dc not hybridize un~der said conditions to nucleic acids of bacteria found in the hama-,n mouth wherein said selective sequence comprises in whole or in part a nucleic acid sequence selected from thQ group consisting o~f: for Bacteroides gingivalis: 'CAATACTCGTATCGCCCGTTATTC3'; 'GTATAAAAGAAGTTTA14AATCCTT3'; CCTTAGGACAGTCTTCCTTCACGC3; f CG'CACCATCAGTCATCTACA1; 50ATTACCCTAGTGCGCCCCTTGCGG3'; and 'CCGATGCTTATTCTTACGGTACAT3'; f or Actinobacillus aex. laenophilus) actinomycetencomitans: CTTCGGGCACYAGGGCTAAACCCC3'; 5'ACCCATCTCTGAGTTCTrTCTTCGG3" an TGGCATGCTATTAACACACCALACC3 p 43 for Daoteroides intermedius Type 1: 'GGTCCTTATTCGAAGGGTAAATGC3'; 51CACGTGCCCCACTTTACTCCCCAA3'; 'TAGCCGCTAACGCCAGGCGCTA-AC3'; CCCTAGGYGCGCTCCTCGCGGTA3'; 'GACTCAACATCTrCTGTATCCTGCG31; and 'TTGCCCTAGGTCGCTCCTCGCCGGT3'; for Bacteroides internedius Typ, 2: 'AGACGCCCCCAAGGAAGCCTATGT3'; 'ATGAGGTACATGCAATGGCGCACA3'; and CGTCCGCCAATTTATTCCCACATA3';* for Bacteroidea forsythus: 'CACAAGGTACIATGCAATAAAATAC3', 5 CGTATCTCATTTTATTCCCCTGTA3'; S*0*5 'AGCTCTCACTCTCCGTCGTCTACA3'; b *a5 'AATACACGTATCTCATTTTATTCC3 g; and 5 'GAAGAAAGCTCTCACTCTCCGTCG3 I; 'CTGTAGAGCTTACACTATATCGCA3'; *toof or Eikenella corrodens: 51 GTACGCTACTAAGCAATCAAGTG3'1 so a 5 'TTAGGTACCGTCAGCAAAAAGTGG3'; 06* 5 'GCACTTCCCTTTTCTrTCCCTAACA3#; STACCGTGGCAAGCGGGCTCCTTGC3'; an 'CTTCCGTCTCTGGAAGGTTCCGTAC3$a; V*t.o for rusobactariwu nuc3.eatum: so S 'CTCATCGTGCACACAGAMTTGCTC13'; 'GTTGGTACCGTCATTTT1TTCTTC3t; AGGTTTCCCCGAAGGCACTGAAAC3 a; 5'TCAGACTCTCGGTCCATTGTCCAA31; and AAACATCTC'rGTCTCATTCCTAAG3$; it'll, 44 for WoJineJ.la recta: 'GTACCGTCATAATTCTTTCCCAAG3'; 5#GGACCATAACCCGTTTGGTATTTC3' 'GCATTACTGCCTCGACTAGCGAG3'; and S 'CTTGGGTACCGTCATAATTCTTTCC32 for Streptococcus intermadius: 1 GTACCGTCACAGTIATGAACTTTCC 1, IITCTCACACTCGTCTTCCTTAAC1; and 1 TTCCATTlCTC~lACTCGTTCTC3; and combinations thereof.

2. A composition of claim 1 wherein the bacteria is I Bacteroides gingivalis and said nucleic acid sequence is selected ~j from the group consisting of: 5'1 CAAT.NCTCGTATCGCCCGTTATTC' 5$GTATAAAAGAAGTTTAMAATCCTT3'0; 5'CCTTAGGACAGTCTTCCTTCACGC3'.3 *5 4 CTGTGGAAGCTGACGGTATATCG3' a 5 'GG'TTTTCACCATCAGTCATCTACA3'; S 'ATTACCCTAGTCCGCCCCTTGCGG3'; 'CCCATCCTTATTICTTACGGTACAT3 and combinations theroof. A composition of claim I. wherein the bacteria is *0 0 Actinobacillus (ex. Haemophilus) act inomycetemncomi ta no and said 9~'nucleic acid sequence is selected from the group consisting of; 'ATTTAACGTCAATTTGGCATGCTA3'1 'CTTCGGGCACYAGGGCTAAACCCC3'; 09 'ACCCATCTCTGAGTTCTTCTTCGG3': 5'GTGGTAAACGCCCCCCTCTCGGTT3'; 'TGCCATCCTATTAACACACCAACC3 an~d combinations thereof.

4. A composition of claim 1 wherein the bacteria is Bacteroides intermedius Type 1 and said nucleic acid sequences is selected from the group consisting of: GGTCCTTATTCGA.AGGGTAAATCC3 t. CACGTGCCCCACTTTACTCCCCAA3' 51TAGCCGCTAACGCCACGCGCTAAC2'; CCCTAGGYGCOCTCCTCGCGGTTA3 1 GAGTCAACATCTCTGTATCCTGCGJ' 'TTGCCCTAGGTCGCTCCTCGCGGT3'; and combinations thereof. A composition of claim 1 wherein the bacterid is Bacteroides intermedius Type 2 and said nucleic acid sequence is selected from the group consisting of: 'AGACGCCCCGAAGGAAGCCTAT-T3' 'ATGAGGTACATGCAATGGCGCACAV' 5 1 CGTGCGCCAkATTTATTCCCACATA3 and combinations thiereof. ii A composition of claim 1 wherein the bacteria is ii Bacteroides forsythus and said nucleic acid sequence is selected fromz the group consisting of: 'CACAAGGTACATGCAATAAAATAC3'; 5 1 CGTATCTCATTTTAT'TCCCCTGTA3 I .544*,5 1 AGCTCTCACTCTCCGTCGTCTACA3'I 'AATACACGTATCTCATTTTATTCC3'; 'CAAGAAAGCTCTCACTCTCCGTCG3'I CT-.-TAGAGCTTACACTATATCGCA3; and combinations thetreof. 46

7. A composition of claim 1 wherein the bacteria is Rikenella corrodens and said nucleic acid sequence is selected from the group consisting of: GTACGCTACTAAGCAATCAAGTTG3'; 'TTAGGTACCOTCAGCAAAAAGTCG31; GCACTTCCCTTTTCTITCCCTAACA3';, 'TACCGTGGCAAGCGGGCTCCrTGC3'; 'CTTCCGTCTCTGGAAGGTTCCGTAC3'; and combinations thereof. 8, A composition of claim 1 wherein the bacteria is Fusobacteriun nucleatum and said nucleic acid sequence is selected from the group consisting of: 'GTCATCGTGCACACAGAATTGCTG3't Sege S o 0 0 5' AGGTTTCCCCGAAGGCACTGAAAC3'; Ii!: TCAQACTCTcGGTCCATTGTCCAA3$ 0000 and combinations thereof.

9. A composition of claim 1 wherein the bacteria is Wolinella recta and said nucleic aaid sequence is selected from the group consisting of: 0000 5'GTACCGTCAAATTCTTTCCCAAG3';$ I. 5' GGACCATAACCGGTTTGOTATTTrG3'; 'GCATTACTGCCTCGACTAGCGAAG3'; II 'CTTGGGTACCGTCATAATTCTTTCC3';* and combinations thereof. j 444 10. A composition of claim I wherein the bacteria is Streptococcus internedius and said nucleic acid sequence is selected from the group consisting of: GTACCGTCACAGTATGAAC'TLTTCC3';, 5tTrCTCACACTCGTTCTTCCTTAAiC3'; 'TTTCCATTCTCACACTCGTTCTTC3'; and combinations theroof. 47

11. A method of detecting, in a sample obtained from the mouth of a human patient, bacteria associated with akzedical disorder, said method comprising the steps of: lysing the microbial cells to free the ribosomal RN~A in said sample; contacting said ribosomal. RNA, under hybridizing conditions, with polynucleotide probes comprising a selective sequence of 10 to 100 nucleotidos or nucleotide analogs capable of seleztively hybridizing to the hypervariable regions off the ribosomal RNAof aaid bacteria: and detecting hybridization complexes as an indication of the presonco of the microbial cell in the sample; wherein said selective sequence conprises in whole or in part a nucleic acid segnant selacted from the group consistin~g of: goeS for Sacteroides gingivalis: 1 W.TACTCGTkTCGCCCGTTATTC3' 'GTATAAAAGAAGTTTAI4AATCCTT3 f- CCTT1AGGACATCTTCCTTCACC3'; 5 gCTGTGGAAGCTTGACGG;TIATCG3' 05' GGTTCACCATCACTcATCTACA3' 'ATTACCCTAGTGCGCCCCTTGCGC3!0 and 'CCGATGCTTATTCTTACGGTACAT'; for Actinobacill-us a xt IaemophiltUs) actinomycetemcoitans: 'ATTTAACGTCAATTI'GGCATGCTA3';, 5' 5 'CTCGGGCACYAGGGCTAAACCCC3'; 1 ACCCATCTCTGAGrTCCTITCGG 3' 'GTGGTAAACGCCCCCCTCTCGGTT3$; and 05 1 TGGCATGCTATTAACACACCAACC3 I; 48 for Bacteroidas intermedius TYpe 1: 'GGTCCTTATTCGAAGGGTAAATGC 2': 1 CACGTGCCCCACTTTACTCCCCA.A3 I 'TAGCCGCTAACGCCAGGCGCTAAC 3'; S 'CCCTAGGYGCGCTCCTCGCGGTTA3 51GAGTCAACATCTCTrGTATCCTGCG3';- and TTGCCCTAGGTCGCTCCTCGCGGT31; for Bacteroidas intormedius Type 2: AGACGCCCCOAAGGAAGCCTATGT3'; ATGAGGTACATGCAATGCGCACA';, and 'CGTGCGCCAATTTATTICCCACATA3'; for Baocercides forsythus: 51 CACAAGGTACATGCAATAAAATAC 3 1 'CGTATCTCATTTITATTCCCCTGTA3'; :000415 IAGCTCTCACTCTCCGTCGTCTACA3'; 066 5 'AATACACGTATCTCATTTTATTCC31, 64*695 'GAAGAAMGCTCTCACTCTCCGTCG3' and *5 'CTGTAGAGCTTACACTATATCGCA2' for Eikenella corredens: GTACGCTACTAAGCAATCAAGTTG 31; 'TTAGGTACCGTCAGCAAAAAGTGG3'; 5 'GCACTTCCCTTTTCTTCCCTAACA#0" TACCGTGGCAAGCGGGCTt%".CTTG3C3'i and oGTTCCGTAC3', for Flasobacteriun nucleatur: S 'GTCATCGTGCACACAOAATTGCTG3$; 5 GTTGGTACCCTCATTTTTTCTC3'; 'AGGTTTCCCCGAAGGCACTGAAAC3'1 'TCAGACTCTCGGTCCATTTCCAA3':, and 'AAACATCTCTGTC'TCATTCCTAAG3':, U. S S U B U 9* 4 *BUO. 0.SS *b 0 9. 0 B *0 B. U S U 49 for Wolinaljla recta: 'GTACCGTCATAATTCTTTCCCAAG 3'; 1 GGACCATAACCGGTTrGGTATTTG 3 1 GCATTACTGCCTCGACTACGAAG3'; and 'CTTGGTACCGTCATATTCMTCC3' for Streptococcus intarinodius: GTACCGTCACAGTATGAACTTTCC32, CTCACACTCGTCTTCCTTAAC3';, and 'TCCATTCTCACACTCGTTCTTC 3'; and combinations thiereof, 12, A method according to cl.aim 11. wherein the b~czer.& is Bacteroides gingivalis and said4 probes comprise a m.olaic acid segment sQ2.ected froz the group consisting of:, 5 'CAATACTCGTATCGCCCGTTATTC3'- 5 'GTATAAAAGAAGTTTAKAATCCTI13'* CCTTAGGACAGTCTTCCTTCACGC3 S 'CTGT=GMGCTTGACGGTATATCCG3( 5 'GOITTCACCATCAGTCATCTACA3'' 5 'ATACCCTGTGCGCCCCTTGCG 03'; CCGATGCMATTCTTIACGGTACAT3'; and a combination thereai?.

13. A method According to claim 11. whoroin the bacteria is Actinohacill1as (ex. liaemophiluo) actinomycoteimcomitano and said probes compritse a nucl.eic acid segment selected from tho group consisting Of! 'ATTrAACGTCMhTTTGGCATGCTA3', 5' CTTC=GCACYAGGGCTAAACCCC3'; V ACCCATCTCTGAGTTCTTMTfCGG31'4 S'GTGGTAAACGCCCCCTCTCGTT3':- 'TGGCATGCThA'TAACACACCU4C3': and combination thereoof,

14. A method according to clam 11 herein the bacteria is Bacteroidces intermedius Type 1 and said probes comprise a nucleic acid segment selected from the group consisting of: SIGGTCCTTATTCGAAG4GGTAAATGC3' S 'CACGTGCCCCACTTTACTCCCCAA3 5'TAGCCGCTAACOCCAGGCGCTAAC3'; 'CCCTAGGYGCGCTCCTCGCGGTTA3I; 5'GAGTCAACATCTCTGTATCCTGCG3'1 TTGCCCTAGGTCGCTCCTCGCGGT3I; and combination thereof. A method according to claim 11 wherein the bacteria is Bacteroidos intermedius Type 2 and said probes comprise a nucleic acid segment selected from the group consisting of: 'AGACGCCCCGAAC-GAAG3CCTATGT31 'ATGAGGTACATGCAATGGCGCACA3 I 'CGTGCGCCAATTTATTCCCACATA31 @*spa, and combination theroof.

16. A method according to claim 11 wherein the bacteria is Bacteroides forsythus and said probes comprise a nucleic acid segment solocted from the group conaisting o(: CACAAGGTACATGCAATAAAATAC3' CGTATCTCATTTTATTCCCCTGTA 3' AGCTCTCACTCTCCGTCGTCTACA31; 5' AATACACGTACTCATTTTATTCC3#t G",GAAAGCTCACTCTCCGTCG31 1 S CTGTAGAGcTTACACTATATCGCA3'j as and combination thereof. 51 1.7. A method according to claim 11 wherein the bacteria is Eikonella corrodens and said probes comprise a naucleic acid sacqment. solected from the group consisting of: 'GTACGCTACTAAGCAATCAAGTTG31, 'TTAGGTACCGTCAGCAAAAAGTGG31'; 'GCACTTrCCCTITTTCI'CCCTMACA3';- 5'TACCGTGGCAAGCCGGCTCCTTGC3'1 S 'CTTCCGCTC1TGGMGGTTCCGTAC3'; and combination thereof.

18. A method according to claim 11 whorein the bacteria is Funobacteriur. nucleat=t and said probes comprise a nucleio acid Gogmernt selected from the group consisting of: 0 0 41 5'QTTGTACCGTCATTTTC3; :0 0: 5 'AGGTTTCCCCGAAGGCACTGAX2AC3', to 5' TCAGACTCTCGGTCCATTGTCCAA3' AAACATC'TCTGTCTCATTCCTAAG3':I a.ad combJination thereof.

19. A mQthod According to claim 11 whorein the bacteria is Wolinalla recta and said probes comprise a nucloic acid sgment selected from the group consisting of: #fe 5 'GTACCGTCATAATTCT TTCCCAAG3# GGACCATAACCGGrTGTATTTG3'; 0 ~SIGCATTACTGCCTCGACTAGCGMAG3'1 CTGGGTACCGTCATAATTCTTTCC3'1 and coombination thoraor, A method according to claimi 2.2 vherein the bacteria is Streptococcus itarzodius And said probes comprise a rnucloic acid segnant selocte4 from the group consistingc or: 'QTACCGTCACAGTATGAkACTTTCC3;j VTTC~ACACTrT~CT'TWAC3'- 'TTCATTCT'CACACTCGTTrCTT1'C3' and combination thereof 4 pF 52

21. A diaqnositic kit for use in datermining the presenco of a specific polynuclootide sequence3 which cozprittas a .,,ynthatic oligonuileotide pr'obe comprising a selective sequence of 1;,to 10, nuO1QOtid~as or nuaootide Analogs complementary to tho 6yperva-iable regioni of the ribosomal RNA of bacteria associated with a human oral medical disorder: wherein said selective sequence comprises in whole or in part a nucleic acid segment stalactad. from the group consisting of: for ED2ctoroides gingivalis: 1 CAATACT(JOTATCGCCCGL'TATJTC3I L' GTATA~AGAAGTTTAMAATCCTT3 1; 'CCTTAGGACAGTCTTCCTTCACGC34 'CTGTGGXAGCTTGACGGTATATCG': 1 lGTTTTCACCATCAGTCATCTICA3 S 'ATTACCCTAGTGCGCCCCTTGCCC3t and "CCGTGCI'ATTCTTACGGTACAT3$; f or ActinobacillUs (eft Iaemophilus) :066 actinomycatemcomit~ns: 'ATTT.BACGTCAATTTGGC'ATOCTA3 S 'M~CGGGCACYAGGGCTAAACCCC3j; 'ACCCATCTCTGAGTTCTTOTTCGG3#1 0 5'GTGGTAAACGCCCCCCT(TCGTT30; and 0 TGGCAT/.'CTATVT.ACACACCAACC3 I 'a *~*for Bacteroides inter~edius Type I.- V GGTCCTTATTCGAAG5GTA.TC3;- 'aCGTGCCCCACTTTACTCCC=A3 I 5TAGCCGCTAACOP.CAGGCGCW.MC3 f 5' CCCTAGGYGCGCTCCItCGCGGTTA3 I; S 'AGTCAACATCTCTGTATCCTGCG3'; and 5OTTGCCCTAGGTCGCTCCTCGCGGT3 I; for Bacteroidoei intermadius TIype 2: 4AGACGCCCCCAAGAAGCCTATGT3' S 'ATGAGGTACATGCAATGGCGCACA3 4: and CGTGCGCCATTTATTCCCACATVA3' for Bacteraides foraythus: CACAAGGTACATGCAATAAA.ATAC31; 1CGTATCTCA=TATTCCCCTG,P AGCTCTCACTCTCCGTCGTCTAcA34; 'AATACACGTATCTCATTTATTCC3#1 'GGAAXUGCTCTICACTCTCCGTCC3';, and 5'1 CTGTAGAGCTACACTATATCGCA3' for Eikenella corrodens: 5'GTACGCTACTAAGCAATCAkAGTTG3'; 0 TTAGGTACCGTrCAGCAAAGTGG3 3'; GCACTTCCCM~TCTTCCCTAACA3#': 5'TACCGTGGCAAGCGGGCTCCTTGC3'; and CTTCCGTCTCTGGAAGGTTCCGTAC3'; for F'usobacterium nUclaatu=: 5'GTCATCOTGCAC.ACGAATTGCT3tj 6to::5!GTT'GGIIIACCGTCATTTTTTCTITC3', AGOTTTCCCCOAAGGCACTGAAAC3 TCAGACTCTCGGTCCATTIGTCCAA3',* and 3 'A.AACATCTCTGTCTCAT1TCCTAAG3'1 for W-'iino11a recta: J 'qACCGTCATAATTCT'TTCCCAAG3'; *1 5' GGACCATMCCGG.rCGTATTTG3'' so S 'GCATTACTCCCTCGACTAGCGA.AG3'; and for str-Optococcus intexlacik"As: S'GTACCGTCACATATGACTTCC3', )TT~l cACACTCGTTC1TTCrAAC30t n S'TTT=TCTCACACTCGTTCTTrC3', and cozbinations thaoof. 54

22. A diagnostic kit according to Claim 21, further comprising a lysing reagent, pr~be/enzyme reagent, dipstick device, j wash reagent, enzyme substrate reagent, and a reference card.

23. A composition of polynucleotide probes for the detection of bacteria associatad with a human oral medical disorder, wheroin said probes comprise a segment of nucleic acid capablQ of selectively hybridizing, under hybridizing conditions, to open regions of ribosomal PITA of the bacteria having minimal secondary or tertiary interactions with adjacent nucleotides, said probes substantially binding only to open regions.

24. A composition according to claim 23 wherein the off* probes slectively hybridize to conserved r'igions of ribosomal. RUA. A composition according to claim 24 wherein said nucleic acid segment is selected from the group consisting of: 1 CCCGTCWATT ',TTGAGTTTT3 I 'TGACGGGCSGTGTGTACAA3'; 'GACTACYMGGGTATCTAATCC3$#; S 'TTAAACCACATGYTCCWCCGC'ITG3i': 0 5 TYGATTGGCMMTCACCCC3':- 5$CCGGTCCTCTCGTACTrA3'; S 'GTATAGTTACGCCCGCCGTTTAC3'; and combinationis thereof. :26. A composition according to clain 23 wherein the probes selectively hybridize to hypervariable regions of ribosomol RNA. iA W( 4 f

27. A compositioni according to Claim 26 wherein said nucleic acid se-ment. is selected from the group consisting of: 'ACCCATCTCTGAGTTCTTCTTCGG3 S 'TGCCATGCTATTAACACACCAACC' CCTTAGGACAGTCTTCCTTCACGC3 'GGTTTCACCATCAGTCATCTACA3; CCGATGCTTATTCTTACGGTACAT3'; CACGTGCCCCACTTTACTCCCCAA3 I GAGTCAACATfCTCTGTATCCTGCG3';- 'CGTGCGCCAATTTATTCCCACATA3' GTACGCTACTAAGCAATCAAGTTrG3; GCACTTCCCTTTTCTTCCCTA.ACA3' 'CTTCCGTCTCTGGAAGGTTWCGTAC3' 'GTTGC-TACCGTCA'lTTT=TCTTC3 I; j *S *e 5'TCAGACTOTCGGTCCATTGTCCAA3 5' AACATCTCTGTCT'CATTCCTkNG3' GTACCG2TCATAATTCTTTCCCAAG3' CTGGGTACCGTCATATTCTTTCC3'; STACGGGTAACACAGAAATATGCTI31; OACTATATACCCAAATTGCTTTT3f# S 'CCTACACATCTATGCCAAATACA3';, and combinations thereof.

28. A method of detecting, in a sample obtained from te mouth of a human patient, bacteria associat~d with a~radical h disorder, said method comprising the steps of: lysing the microbial cells to free the rib-9somal RNA in 6 aid sample; contacting said ribosomal RNA, under hybridizing conditions, with palynuclootide probes capable of selectively hybridizing to open reglons of the ribosomal. RNA having ninital secondary and tertiary interactions with adjacent nuclaoties and detecting hybridizaition complexesi as an indication of the presence of the microbial coell. in the 'sample. 56

29. A method according to claim 28 wherein thG hybridizing conditions do not include denaturing the ribosomal RNA in the z-ample. A method according to claim 28 wherein said probes are capable of hybridizing to the ribosomal RNA of bactr, ria selected from the group consisting of Actinobacillus (ex. Iiaemophilus) actinomycetemoomitans, Bacteroides gingivalis, Bacteroides intermadius Type 1$ Bacteroides intermadius Typo 2, Mi1enella corrodons, Bacteroides forsythus, Fusobacterium 4 nticleatum, Fusobacterium periodonticu=, Streptococcus intarmedius, and WolinelJla rccta, and combinations thereof, S31,. A method according to claim 30 wherein the saraple too* I is assayed using at least two different groups of probes where each I group is capabl.e of hybridizing to different hypervariabla or conserved regions of the ribosona. PA of a single bacteriun. *see.. 000 so: S. S 0* S S S S. S S* A UI 57

32. A composition of polynucleotide probes for the detection of bacteria associated with a human oral medical disorder, wherein said probes comprise a segment of nucleic acid capable of selectively hybridizing, under hybridizing conditions) to conserved regions of ribosomal RNA of the bacteria with the provision that any additional nucleotides covalently bound to said segment do not hybridize under said conditions to nucleic acids of bacteria found in the human mouth, and further wherein said nucleic acid segment ia selected from a group consisting of: 5GCTGGCACGGAGTTAGCCG3'; 5'CCCGTCWATTC'MTTTGAGTTT3#; 1GCC kTCTATCC !GTTYG CTCC3' t5 1 GC.,G-'iTrCTTTTCGCCTTCC3'; SSICTTAGATGCT'ITCAC3'i 0. 5 'GGACCGACTGTCTCACGACGTTCT3 0690 5' GACCGCCCCAGTCAAACT3',,- 1CCCG ACAA AA ITCGC3 ICCTCTCCCGAAGTTACG3't 'G-ACCAGTGAGCTM1TACCC3#; i 5TTCGGGGAGAACCAaCTA3'; 5'TGCOGGCGGTGTGTACAA3'; 5 'GACTACYMGGGTATCTAATCC3 00*0 TTAAACCACATGYTCCWCCOCTTG3' 4 5'TYGATTCGcMTrcACCCC3"; CCGGTCCTCTC GTAcUTA3'; TTCGCTCGCCcCTACT3' T' TAGTACGGCCOCCGTTTAC3'i go :and combinations thereof. SC 0 *~e -58-

33. A ccmposition of polynucleotide probes, substantially as herein described, with reference to any one of Exairples 1 to 3.

34. A diagnostic kit, substantially as herein described, with reference to Example 4. DAT7ED this 23rd day of August, 1990. MICPROBE CORPORATICN By TerPatent Attorneys ARPHEJ S CAVE CO .*Ogg. S.